How the therapeutic cancer drug lenalidomide impacts Natural Killer cell immune responses
As multiple myeloma (MM) progresses, Natural Killer (NK) cell responses decline against malignant plasma cells. The immunomodulatory drug lenalidomide is widely used for the treatment of MM but its influence on NK cell biology is unclear. Here, a combination of functional assays and microscopy techn...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.676822 |